Your browser doesn't support javascript.
loading
Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial.
Charton, Emilie; Bachet, Jean-Baptiste; Hammel, Pascal; Desramé, Jérôme; Chibaudel, Benoist; Cohen, Romain; Debourdeau, Philippe; Dauba, Jérome; Lecomte, Thierry; Seitz, Jean-François; Tournigand, Christophe; Aparicio, Thomas; Guerin-Meyer, Véronique; Taieb, Julien; Volet, Julien; Louvet, Christophe; Anota, Amélie; Bonnetain, Franck.
Afiliação
  • Charton E; Methodology and Quality of Life Unit in Oncology, INSERM UMR 1098, University Hospital of Besançon, Besançon, France.
  • Bachet JB; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Hammel P; Department of Hepato-Gastroenterology, Groupe hospitalier Pitié Salpêtrière, Sorbonne University, UPMC University, Paris, France.
  • Desramé J; Department of Digestive Oncology, Hôpital Beaujon, Clichy, France.
  • Chibaudel B; Department of Hepato-Gastroenterology, Hôpital Privé Jean Mermoz, Lyon, France.
  • Cohen R; Department of Oncology, Institut Franco-Britannique, Levallois-Perret, France.
  • Debourdeau P; Department of Oncology, AP-HP, Hôpital Saint-Antoine, Sorbonne University, Paris, France.
  • Dauba J; Department of Oncology, Institut Saint Catherine, Avignon, France.
  • Lecomte T; Department of Oncology, Hôpital Layne Mont de Marsan, Mont de Marsan, France.
  • Seitz JF; Department of Hepato-Gastroenterology, Hôpital Trousseau, Tours, France.
  • Tournigand C; CHU La Timone, Marseille, France.
  • Aparicio T; Department of Oncology, CHU Henri Mondor, Créteil, France.
  • Guerin-Meyer V; Department of Hepato-Gastroenterology, CHU Saint Louis, Paris, France.
  • Taieb J; Department of Oncology, Institut de cancérologie de L'Ouest Paul Papin, Angers, France.
  • Volet J; Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges Pompidou, Paris, France.
  • Louvet C; Department of Hepato-Gastroenterology, CHU Robert Debré, Reims, France.
  • Anota A; Department of Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Bonnetain F; Methodology and Quality of Life Unit in Oncology, INSERM UMR 1098, University Hospital of Besançon, Besançon, France.
Cancer Med ; 8(11): 5079-5088, 2019 Sep.
Article em En | MEDLINE | ID: mdl-31314957
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Qualidade de Vida / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Qualidade de Vida / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2019 Tipo de documento: Article